Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma
Abstract Background Urothelial carcinoma (UC) is among the most prevalent malignancies. The muscle-invasive bladder cancer (MIBC) shows an invasive feature and has poor prognosis, while the non-muscle invasive bladder cancer (NMIBC) shows a better prognosis as compared with the MIBC. However, a sign...
Main Authors: | Qiongqiong Lin, Lu Pei, Zhiguang Zhao, Xiaoping Zhuang, Haide Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-09884-8 |
Similar Items
-
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
by: Hong-Lin He, et al.
Published: (2023-02-01) -
Editorial: Therapies and influences in urothelial carcinoma
by: G. Ozgun, et al.
Published: (2022-12-01) -
Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
by: Dong Chen, et al.
Published: (2021-12-01) -
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35
by: Roberto De Masi, et al.
Published: (2021-11-01) -
Purification and Partial Characterization of β-Glucosidase in Chayote (Sechium edule)
by: Sergio Espíndola Mateos, et al.
Published: (2015-10-01)